Wednesday, 08/04/2010
|
Assessing the Impact of Tumor Heterogeneity on Powering Microarray Signature Discovery
Timothy Scott Davison, Almac Diagnostics; Sian Dibben, Almac Diagnostics; Janet Taylor, Almac Diagnostics; Robert J. Holt, Almac Diagnostics; Paul J. Kelly, Belfast Health and Social Care Trust; Ian Paul, Queen's University Belfast; Peter Kerr, Almac Diagnostics; Dean A. Fennell, Queen's University Belfast; Jacqueline A. James, Queen's University Belfast; Richard D. Kennedy, Almac Diagnostics
|
On the Correlated Gamma Frailty Model for Bivariate Current Status Data
Niel Hens, Hasselt University; Andreas Wienke, University Halle-Wittenberg
8:50 AM
|
Heterogeneity of Variance in One-Way Random Effect Model: A Meta-Analysis Review of the National Health Interview Survey Data
Abera Wouhib, National Center for Health Statistics; Myron Katzoff, CDC; Meena Khare, National Center for Health Statistics
9:35 AM
|
Bias Correction in the Hierarchical Likelihood Approach to the Analysis of Multivariate Survival Data
Jihyoun Jeon, Fred Hutchinson Cancer Research Center; Li Hsu, Fred Hutchinson Cancer Research Center; Malka Gorfine, Technion - Israel Institute of Technology
2:50 PM
|
|